nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA2—stomach cancer	0.377	0.438	CbGaD
Dobutamine—ADRB1—stomach cancer	0.262	0.305	CbGaD
Dobutamine—ADRB2—stomach cancer	0.221	0.257	CbGaD
Dobutamine—CA5A—endocrine gland—stomach cancer	0.00208	0.0913	CbGeAlD
Dobutamine—CA5A—liver—stomach cancer	0.00187	0.0823	CbGeAlD
Dobutamine—Angina pectoris—Floxuridine—stomach cancer	0.00178	0.0556	CcSEcCtD
Dobutamine—Skin necrosis—Methotrexate—stomach cancer	0.00142	0.0442	CcSEcCtD
Dobutamine—CA2—gall bladder—stomach cancer	0.00142	0.0623	CbGeAlD
Dobutamine—CA5B—hematopoietic system—stomach cancer	0.0014	0.0616	CbGeAlD
Dobutamine—Skin necrosis—Epirubicin—stomach cancer	0.00133	0.0414	CcSEcCtD
Dobutamine—COMT—hematopoietic system—stomach cancer	0.00129	0.0567	CbGeAlD
Dobutamine—Skin necrosis—Doxorubicin—stomach cancer	0.00123	0.0383	CcSEcCtD
Dobutamine—CA5B—pancreas—stomach cancer	0.00114	0.0501	CbGeAlD
Dobutamine—COMT—smooth muscle tissue—stomach cancer	0.00114	0.05	CbGeAlD
Dobutamine—COMT—pancreas—stomach cancer	0.00105	0.0462	CbGeAlD
Dobutamine—Thrombocytopenia—Floxuridine—stomach cancer	0.00102	0.0318	CcSEcCtD
Dobutamine—Masoprocol—ALOX5—stomach cancer	0.00102	0.135	CrCbGaD
Dobutamine—COMT—digestive system—stomach cancer	0.000897	0.0395	CbGeAlD
Dobutamine—COMT—bone marrow—stomach cancer	0.000827	0.0364	CbGeAlD
Dobutamine—CA5B—endocrine gland—stomach cancer	0.000805	0.0354	CbGeAlD
Dobutamine—CA2—hematopoietic system—stomach cancer	0.000801	0.0352	CbGeAlD
Dobutamine—Thrombocytopenia—Mitomycin—stomach cancer	0.000799	0.0249	CcSEcCtD
Dobutamine—COMT—endocrine gland—stomach cancer	0.000741	0.0326	CbGeAlD
Dobutamine—Ventricular extrasystoles—Capecitabine—stomach cancer	0.000736	0.023	CcSEcCtD
Dobutamine—CA2—epithelium—stomach cancer	0.000733	0.0322	CbGeAlD
Dobutamine—Dyspnoea—Mitomycin—stomach cancer	0.000728	0.0227	CcSEcCtD
Dobutamine—CA2—smooth muscle tissue—stomach cancer	0.000706	0.031	CbGeAlD
Dobutamine—COMT—liver—stomach cancer	0.000668	0.0294	CbGeAlD
Dobutamine—Hypokalaemia—Irinotecan—stomach cancer	0.000656	0.0205	CcSEcCtD
Dobutamine—Skin exfoliation—Docetaxel—stomach cancer	0.000656	0.0205	CcSEcCtD
Dobutamine—CA2—pancreas—stomach cancer	0.000653	0.0287	CbGeAlD
Dobutamine—Headache—Floxuridine—stomach cancer	0.000652	0.0203	CcSEcCtD
Dobutamine—Skin exfoliation—Capecitabine—stomach cancer	0.000635	0.0198	CcSEcCtD
Dobutamine—ADRB1—endocrine gland—stomach cancer	0.000628	0.0276	CbGeAlD
Dobutamine—Nausea—Floxuridine—stomach cancer	0.000618	0.0193	CcSEcCtD
Dobutamine—Angina pectoris—Irinotecan—stomach cancer	0.000607	0.0189	CcSEcCtD
Dobutamine—Angina pectoris—Fluorouracil—stomach cancer	0.000582	0.0181	CcSEcCtD
Dobutamine—Phlebitis—Docetaxel—stomach cancer	0.000579	0.0181	CcSEcCtD
Dobutamine—CA2—lymphoid tissue—stomach cancer	0.000564	0.0248	CbGeAlD
Dobutamine—Phlebitis—Capecitabine—stomach cancer	0.00056	0.0175	CcSEcCtD
Dobutamine—Fenoterol—ADRB1—stomach cancer	0.000558	0.0743	CrCbGaD
Dobutamine—CA2—digestive system—stomach cancer	0.000557	0.0245	CbGeAlD
Dobutamine—CA5B—lymph node—stomach cancer	0.000556	0.0245	CbGeAlD
Dobutamine—Arbutamine—ADRB1—stomach cancer	0.000522	0.0695	CrCbGaD
Dobutamine—Arformoterol—CYP2A6—stomach cancer	0.000522	0.0694	CrCbGaD
Dobutamine—Formoterol—CYP2A6—stomach cancer	0.000522	0.0694	CrCbGaD
Dobutamine—CA2—bone marrow—stomach cancer	0.000514	0.0226	CbGeAlD
Dobutamine—Ventricular extrasystoles—Epirubicin—stomach cancer	0.000513	0.016	CcSEcCtD
Dobutamine—COMT—lymph node—stomach cancer	0.000512	0.0225	CbGeAlD
Dobutamine—Headache—Mitomycin—stomach cancer	0.000511	0.016	CcSEcCtD
Dobutamine—Formoterol—ADRB1—stomach cancer	0.000507	0.0675	CrCbGaD
Dobutamine—Arformoterol—ADRB1—stomach cancer	0.000507	0.0675	CrCbGaD
Dobutamine—Nausea—Mitomycin—stomach cancer	0.000485	0.0151	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.000475	0.0148	CcSEcCtD
Dobutamine—Skin exfoliation—Methotrexate—stomach cancer	0.000473	0.0147	CcSEcCtD
Dobutamine—Ritodrine—ADRB2—stomach cancer	0.00047	0.0625	CrCbGaD
Dobutamine—Fenoterol—ADRB2—stomach cancer	0.00047	0.0625	CrCbGaD
Dobutamine—CA2—endocrine gland—stomach cancer	0.000461	0.0203	CbGeAlD
Dobutamine—Skin exfoliation—Epirubicin—stomach cancer	0.000442	0.0138	CcSEcCtD
Dobutamine—Hypokalaemia—Capecitabine—stomach cancer	0.000439	0.0137	CcSEcCtD
Dobutamine—Arbutamine—ADRB2—stomach cancer	0.000439	0.0584	CrCbGaD
Dobutamine—Formoterol—ADRB2—stomach cancer	0.000426	0.0567	CrCbGaD
Dobutamine—Arformoterol—ADRB2—stomach cancer	0.000426	0.0567	CrCbGaD
Dobutamine—Angina pectoris—Docetaxel—stomach cancer	0.00042	0.0131	CcSEcCtD
Dobutamine—CA2—liver—stomach cancer	0.000415	0.0183	CbGeAlD
Dobutamine—Skin exfoliation—Doxorubicin—stomach cancer	0.000409	0.0128	CcSEcCtD
Dobutamine—Angina pectoris—Capecitabine—stomach cancer	0.000406	0.0127	CcSEcCtD
Dobutamine—Phlebitis—Epirubicin—stomach cancer	0.00039	0.0122	CcSEcCtD
Dobutamine—Labetalol—ADRB1—stomach cancer	0.000371	0.0493	CrCbGaD
Dobutamine—Phlebitis—Doxorubicin—stomach cancer	0.000361	0.0113	CcSEcCtD
Dobutamine—Chest pain—Fluorouracil—stomach cancer	0.000354	0.0111	CcSEcCtD
Dobutamine—Thrombocytopenia—Irinotecan—stomach cancer	0.000347	0.0108	CcSEcCtD
Dobutamine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000332	0.0104	CcSEcCtD
Dobutamine—Tachycardia—Fluorouracil—stomach cancer	0.000331	0.0103	CcSEcCtD
Dobutamine—Hypotension—Irinotecan—stomach cancer	0.000331	0.0103	CcSEcCtD
Dobutamine—CA2—lymph node—stomach cancer	0.000318	0.014	CbGeAlD
Dobutamine—Hypotension—Fluorouracil—stomach cancer	0.000317	0.0099	CcSEcCtD
Dobutamine—Dyspnoea—Irinotecan—stomach cancer	0.000316	0.00986	CcSEcCtD
Dobutamine—Labetalol—ADRB2—stomach cancer	0.000312	0.0415	CrCbGaD
Dobutamine—Hypokalaemia—Epirubicin—stomach cancer	0.000306	0.00955	CcSEcCtD
Dobutamine—Dyspnoea—Fluorouracil—stomach cancer	0.000303	0.00944	CcSEcCtD
Dobutamine—Hypokalaemia—Doxorubicin—stomach cancer	0.000283	0.00884	CcSEcCtD
Dobutamine—Angina pectoris—Epirubicin—stomach cancer	0.000283	0.00883	CcSEcCtD
Dobutamine—Palpitations—Docetaxel—stomach cancer	0.000265	0.00828	CcSEcCtD
Dobutamine—Angina pectoris—Doxorubicin—stomach cancer	0.000262	0.00817	CcSEcCtD
Dobutamine—Palpitations—Capecitabine—stomach cancer	0.000257	0.00802	CcSEcCtD
Dobutamine—Chest pain—Docetaxel—stomach cancer	0.000256	0.00798	CcSEcCtD
Dobutamine—Chest pain—Capecitabine—stomach cancer	0.000247	0.00772	CcSEcCtD
Dobutamine—Pruritus—Fluorouracil—stomach cancer	0.00024	0.00749	CcSEcCtD
Dobutamine—Thrombocytopenia—Docetaxel—stomach cancer	0.00024	0.00749	CcSEcCtD
Dobutamine—Tachycardia—Docetaxel—stomach cancer	0.000239	0.00746	CcSEcCtD
Dobutamine—Dopamine—ADRB1—stomach cancer	0.000235	0.0312	CrCbGaD
Dobutamine—Thrombocytopenia—Capecitabine—stomach cancer	0.000232	0.00725	CcSEcCtD
Dobutamine—Tachycardia—Capecitabine—stomach cancer	0.000232	0.00722	CcSEcCtD
Dobutamine—Hypotension—Docetaxel—stomach cancer	0.000229	0.00714	CcSEcCtD
Dobutamine—Headache—Irinotecan—stomach cancer	0.000222	0.00693	CcSEcCtD
Dobutamine—Hypotension—Capecitabine—stomach cancer	0.000222	0.00692	CcSEcCtD
Dobutamine—Dyspnoea—Docetaxel—stomach cancer	0.000218	0.00682	CcSEcCtD
Dobutamine—Headache—Fluorouracil—stomach cancer	0.000213	0.00664	CcSEcCtD
Dobutamine—Dyspnoea—Capecitabine—stomach cancer	0.000212	0.0066	CcSEcCtD
Dobutamine—Nausea—Irinotecan—stomach cancer	0.000211	0.00657	CcSEcCtD
Dobutamine—Dopamine—HTR1A—stomach cancer	0.00021	0.0279	CrCbGaD
Dobutamine—Nausea—Fluorouracil—stomach cancer	0.000202	0.00629	CcSEcCtD
Dobutamine—Chest pain—Methotrexate—stomach cancer	0.000184	0.00575	CcSEcCtD
Dobutamine—Palpitations—Epirubicin—stomach cancer	0.000179	0.00558	CcSEcCtD
Dobutamine—Pruritus—Docetaxel—stomach cancer	0.000173	0.00541	CcSEcCtD
Dobutamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000173	0.0054	CcSEcCtD
Dobutamine—Chest pain—Epirubicin—stomach cancer	0.000172	0.00538	CcSEcCtD
Dobutamine—Pruritus—Capecitabine—stomach cancer	0.000168	0.00524	CcSEcCtD
Dobutamine—Palpitations—Doxorubicin—stomach cancer	0.000166	0.00517	CcSEcCtD
Dobutamine—Hypotension—Methotrexate—stomach cancer	0.000165	0.00515	CcSEcCtD
Dobutamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000162	0.00505	CcSEcCtD
Dobutamine—Tachycardia—Epirubicin—stomach cancer	0.000161	0.00503	CcSEcCtD
Dobutamine—Chest pain—Doxorubicin—stomach cancer	0.00016	0.00498	CcSEcCtD
Dobutamine—Dyspnoea—Methotrexate—stomach cancer	0.000157	0.00491	CcSEcCtD
Dobutamine—Hypotension—Epirubicin—stomach cancer	0.000154	0.00482	CcSEcCtD
Dobutamine—Headache—Docetaxel—stomach cancer	0.000154	0.00479	CcSEcCtD
Dobutamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.00015	0.00467	CcSEcCtD
Dobutamine—Tachycardia—Doxorubicin—stomach cancer	0.000149	0.00466	CcSEcCtD
Dobutamine—Headache—Capecitabine—stomach cancer	0.000149	0.00464	CcSEcCtD
Dobutamine—Dyspnoea—Epirubicin—stomach cancer	0.000147	0.0046	CcSEcCtD
Dobutamine—Nausea—Docetaxel—stomach cancer	0.000146	0.00454	CcSEcCtD
Dobutamine—Hypotension—Doxorubicin—stomach cancer	0.000143	0.00446	CcSEcCtD
Dobutamine—Nausea—Capecitabine—stomach cancer	0.000141	0.0044	CcSEcCtD
Dobutamine—Dyspnoea—Doxorubicin—stomach cancer	0.000136	0.00425	CcSEcCtD
Dobutamine—Pruritus—Methotrexate—stomach cancer	0.000125	0.0039	CcSEcCtD
Dobutamine—Pruritus—Epirubicin—stomach cancer	0.000117	0.00365	CcSEcCtD
Dobutamine—Headache—Methotrexate—stomach cancer	0.000111	0.00345	CcSEcCtD
Dobutamine—Pruritus—Doxorubicin—stomach cancer	0.000108	0.00338	CcSEcCtD
Dobutamine—Nausea—Methotrexate—stomach cancer	0.000105	0.00327	CcSEcCtD
Dobutamine—Headache—Epirubicin—stomach cancer	0.000104	0.00323	CcSEcCtD
Dobutamine—Nausea—Epirubicin—stomach cancer	9.82e-05	0.00306	CcSEcCtD
Dobutamine—Headache—Doxorubicin—stomach cancer	9.58e-05	0.00299	CcSEcCtD
Dobutamine—Nausea—Doxorubicin—stomach cancer	9.08e-05	0.00283	CcSEcCtD
Dobutamine—CA5B—Metabolism—HMOX1—stomach cancer	4.88e-05	0.000625	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALOX5—stomach cancer	4.87e-05	0.000624	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GSTM1—stomach cancer	4.87e-05	0.000624	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKR1C3—stomach cancer	4.86e-05	0.000623	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KISS1—stomach cancer	4.81e-05	0.000616	CbGpPWpGaD
Dobutamine—COMT—Metabolism—DPYD—stomach cancer	4.79e-05	0.000614	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ENO1—stomach cancer	4.73e-05	0.000607	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KISS1—stomach cancer	4.7e-05	0.000603	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TYMS—stomach cancer	4.6e-05	0.000589	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ERCC2—stomach cancer	4.58e-05	0.000587	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GAST—stomach cancer	4.55e-05	0.000583	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—RGS2—stomach cancer	4.55e-05	0.000583	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GSTM1—stomach cancer	4.54e-05	0.000582	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—HRAS—stomach cancer	4.49e-05	0.000575	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—ADRB2—stomach cancer	4.45e-05	0.000571	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GAST—stomach cancer	4.45e-05	0.000571	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—RGS2—stomach cancer	4.45e-05	0.000571	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GLI3—stomach cancer	4.41e-05	0.000565	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KISS1R—stomach cancer	4.41e-05	0.000565	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GLI3—stomach cancer	4.31e-05	0.000552	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KISS1R—stomach cancer	4.31e-05	0.000552	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—stomach cancer	4.3e-05	0.000551	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—MAPK1—stomach cancer	4.28e-05	0.000549	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ERCC2—stomach cancer	4.27e-05	0.000548	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTT1—stomach cancer	4.23e-05	0.000543	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RBP1—stomach cancer	4.2e-05	0.000539	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CD44—stomach cancer	4.2e-05	0.000538	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP2A6—stomach cancer	4.19e-05	0.000536	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RGS2—stomach cancer	4.13e-05	0.00053	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GAST—stomach cancer	4.13e-05	0.00053	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RBP1—stomach cancer	4.11e-05	0.000527	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKR1C3—stomach cancer	4.07e-05	0.000522	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GAST—stomach cancer	4.04e-05	0.000518	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RGS2—stomach cancer	4.04e-05	0.000518	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—stomach cancer	4.02e-05	0.000515	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ENO1—stomach cancer	3.97e-05	0.000509	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CAV1—stomach cancer	3.97e-05	0.000509	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—APOA1—stomach cancer	3.96e-05	0.000507	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CAV1—stomach cancer	3.7e-05	0.000475	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOA1—stomach cancer	3.7e-05	0.000474	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPP2R1A—stomach cancer	3.57e-05	0.000458	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CD44—stomach cancer	3.52e-05	0.000451	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTP1—stomach cancer	3.5e-05	0.000449	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—stomach cancer	3.49e-05	0.000447	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HMOX1—stomach cancer	3.45e-05	0.000443	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	3.45e-05	0.000442	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—HRAS—stomach cancer	3.44e-05	0.000441	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—WWOX—stomach cancer	3.43e-05	0.000439	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—F2R—stomach cancer	3.41e-05	0.000437	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	3.37e-05	0.000432	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—WWOX—stomach cancer	3.35e-05	0.00043	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—F2R—stomach cancer	3.34e-05	0.000428	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	3.32e-05	0.000426	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—stomach cancer	3.26e-05	0.000417	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TYMS—stomach cancer	3.26e-05	0.000417	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	3.25e-05	0.000416	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTM1—stomach cancer	3.22e-05	0.000413	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	3.21e-05	0.000411	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRH4—stomach cancer	3.19e-05	0.000408	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—WIF1—stomach cancer	3.19e-05	0.000408	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	3.14e-05	0.000402	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ALB—stomach cancer	3.14e-05	0.000402	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	3.13e-05	0.000401	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—WIF1—stomach cancer	3.12e-05	0.000399	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRH4—stomach cancer	3.12e-05	0.000399	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—F2R—stomach cancer	3.1e-05	0.000397	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	3.06e-05	0.000393	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	3.04e-05	0.000389	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—F2R—stomach cancer	3.03e-05	0.000388	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ERCC2—stomach cancer	3.03e-05	0.000388	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	3.01e-05	0.000386	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NOS3—stomach cancer	3e-05	0.000385	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPP2R1A—stomach cancer	2.99e-05	0.000384	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	2.95e-05	0.000378	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	2.94e-05	0.000377	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTP1—stomach cancer	2.93e-05	0.000376	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ALB—stomach cancer	2.93e-05	0.000375	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	2.91e-05	0.000373	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—stomach cancer	2.89e-05	0.000371	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	2.88e-05	0.000369	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	2.85e-05	0.000365	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—stomach cancer	2.84e-05	0.000365	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RNF43—stomach cancer	2.84e-05	0.000364	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KISS1—stomach cancer	2.84e-05	0.000364	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.82e-05	0.000362	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NOS3—stomach cancer	2.8e-05	0.000359	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KISS1—stomach cancer	2.78e-05	0.000356	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RNF43—stomach cancer	2.78e-05	0.000356	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.76e-05	0.000354	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	2.76e-05	0.000354	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—stomach cancer	2.74e-05	0.000352	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TYMS—stomach cancer	2.73e-05	0.00035	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTM1—stomach cancer	2.7e-05	0.000346	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CAV1—stomach cancer	2.62e-05	0.000336	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOA1—stomach cancer	2.62e-05	0.000336	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—stomach cancer	2.56e-05	0.000328	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ERCC2—stomach cancer	2.54e-05	0.000325	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FST—stomach cancer	2.53e-05	0.000324	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	2.52e-05	0.000322	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	2.48e-05	0.000317	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FST—stomach cancer	2.48e-05	0.000317	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RGS2—stomach cancer	2.44e-05	0.000313	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAST—stomach cancer	2.44e-05	0.000313	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	2.42e-05	0.00031	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RGS2—stomach cancer	2.39e-05	0.000306	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAST—stomach cancer	2.39e-05	0.000306	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—stomach cancer	2.38e-05	0.000306	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGG—stomach cancer	2.31e-05	0.000297	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—stomach cancer	2.31e-05	0.000296	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	2.28e-05	0.000293	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGG—stomach cancer	2.26e-05	0.00029	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	2.24e-05	0.000287	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	2.23e-05	0.000286	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAV1—stomach cancer	2.2e-05	0.000282	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOA1—stomach cancer	2.19e-05	0.000281	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	2.19e-05	0.000281	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	2.18e-05	0.000279	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RBP4—stomach cancer	2.15e-05	0.000276	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	2.15e-05	0.000276	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RBP4—stomach cancer	2.1e-05	0.00027	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	2.1e-05	0.00027	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—stomach cancer	2.07e-05	0.000266	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NOS3—stomach cancer	1.98e-05	0.000254	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—stomach cancer	1.93e-05	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HSPB1—stomach cancer	1.85e-05	0.000237	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR2—stomach cancer	1.85e-05	0.000237	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BMP2—stomach cancer	1.83e-05	0.000234	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—F2R—stomach cancer	1.83e-05	0.000234	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—stomach cancer	1.81e-05	0.000233	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR2—stomach cancer	1.81e-05	0.000232	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HSPB1—stomach cancer	1.81e-05	0.000232	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	1.8e-05	0.000231	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—F2R—stomach cancer	1.79e-05	0.000229	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BMP2—stomach cancer	1.79e-05	0.000229	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR1A—stomach cancer	1.78e-05	0.000228	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	1.76e-05	0.000226	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR1A—stomach cancer	1.74e-05	0.000223	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—stomach cancer	1.74e-05	0.000223	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	1.72e-05	0.000221	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ANXA1—stomach cancer	1.72e-05	0.00022	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—stomach cancer	1.69e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	1.69e-05	0.000216	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ANXA1—stomach cancer	1.68e-05	0.000216	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NOS3—stomach cancer	1.66e-05	0.000213	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.63e-05	0.000209	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.59e-05	0.000204	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—stomach cancer	1.58e-05	0.000202	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.57e-05	0.000201	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.56e-05	0.0002	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.56e-05	0.0002	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.53e-05	0.000196	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.53e-05	0.000196	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—stomach cancer	1.52e-05	0.000195	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.46e-05	0.000187	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.43e-05	0.000183	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.39e-05	0.000178	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.38e-05	0.000177	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.36e-05	0.000174	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.35e-05	0.000174	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.35e-05	0.000173	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.32e-05	0.00017	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.29e-05	0.000166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.26e-05	0.000161	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.23e-05	0.000158	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.23e-05	0.000157	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.22e-05	0.000156	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.2e-05	0.000154	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.19e-05	0.000152	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FYN—stomach cancer	1.17e-05	0.000149	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FYN—stomach cancer	1.14e-05	0.000146	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—stomach cancer	1.12e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.1e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.09e-05	0.00014	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	1.08e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGFR2—stomach cancer	1.07e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS2—stomach cancer	1e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS2—stomach cancer	9.8e-06	0.000126	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CAV1—stomach cancer	9.72e-06	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOA1—stomach cancer	9.7e-06	0.000124	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CAV1—stomach cancer	9.51e-06	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOA1—stomach cancer	9.49e-06	0.000122	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—stomach cancer	9.35e-06	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCB—stomach cancer	9.25e-06	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6ST—stomach cancer	9.21e-06	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCB—stomach cancer	9.05e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6ST—stomach cancer	9.01e-06	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APC—stomach cancer	8.85e-06	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APC—stomach cancer	8.66e-06	0.000111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	8.48e-06	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	8.29e-06	0.000106	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6R—stomach cancer	8.22e-06	0.000105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	8.07e-06	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—stomach cancer	8.07e-06	0.000103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6R—stomach cancer	8.04e-06	0.000103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	7.89e-06	0.000101	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—stomach cancer	7.89e-06	0.000101	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	7.71e-06	9.88e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	7.7e-06	9.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—stomach cancer	7.62e-06	9.77e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	7.54e-06	9.66e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	7.53e-06	9.65e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—stomach cancer	7.45e-06	9.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RHOA—stomach cancer	7.43e-06	9.52e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOS3—stomach cancer	7.35e-06	9.42e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RHOA—stomach cancer	7.26e-06	9.31e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOS3—stomach cancer	7.19e-06	9.21e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	7e-06	8.97e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ERBB2—stomach cancer	6.87e-06	8.81e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	6.85e-06	8.78e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ERBB2—stomach cancer	6.72e-06	8.62e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—stomach cancer	6.52e-06	8.36e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—stomach cancer	6.48e-06	8.3e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—stomach cancer	6.38e-06	8.17e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	6.37e-06	8.16e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—stomach cancer	6.34e-06	8.12e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	6.23e-06	7.98e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—stomach cancer	6.2e-06	7.94e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—stomach cancer	6.07e-06	7.78e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—stomach cancer	6.06e-06	7.77e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUN—stomach cancer	6.06e-06	7.77e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—stomach cancer	5.94e-06	7.61e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUN—stomach cancer	5.93e-06	7.6e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—stomach cancer	5.9e-06	7.56e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	5.87e-06	7.53e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—stomach cancer	5.77e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	5.75e-06	7.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—stomach cancer	5.73e-06	7.35e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—stomach cancer	5.61e-06	7.19e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—stomach cancer	5.29e-06	6.79e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—stomach cancer	5.24e-06	6.72e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—stomach cancer	5.18e-06	6.64e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—stomach cancer	5.13e-06	6.57e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK3—stomach cancer	5.01e-06	6.42e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK3—stomach cancer	4.9e-06	6.28e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—stomach cancer	4.87e-06	6.24e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK1—stomach cancer	4.77e-06	6.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—stomach cancer	4.76e-06	6.11e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—stomach cancer	4.76e-06	6.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK1—stomach cancer	4.66e-06	5.97e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—stomach cancer	4.66e-06	5.97e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—stomach cancer	4.5e-06	5.77e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—stomach cancer	4.4e-06	5.64e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	4.14e-06	5.3e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	4.04e-06	5.18e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—stomach cancer	4e-06	5.13e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—stomach cancer	3.91e-06	5.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—stomach cancer	3.83e-06	4.9e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—stomach cancer	3.74e-06	4.8e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—stomach cancer	3.66e-06	4.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—stomach cancer	3.58e-06	4.59e-05	CbGpPWpGaD
